Zika Virus: Updates to Clinical Guidance and Recommendations for Pregnant Women and Infants
= Date:Thursday, July 27, 2017
Time: 2:00-3:00 pm (Eastern Time)
Overview
CDC has updated its interim guidance for pregnant women with possible exposure to Zika virus to include separate recommendations for pregnant women with symptoms and pregnant women without symptoms. In addition, CDC recently released its latest findings from the Zika pregnancy and infant registries on pregnancy outcomes for pregnant women with Zika virus infection in the U.S. territories and has new updates for healthcare providers on pediatric ophthalmologic findings in infants with possible congenital Zika virus exposure. During this COCA Call, clinicians will learn about the recent updates to CDC’s interim guidance for pregnant women with possible exposure to Zika virus; hear about the latest findings on pregnancy outcomes in the U.S. territories, based on the Zika pregnancy and infant registries; and receive new information on pediatric ophthalmologic findings to assist in caring for patients based on currently available data.
Dana Meaney-Delman, MD, MPH
Senior Medical Officer
Office of Infectious Disease
National Center for Emerging & Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Sasapin Grace Prakalapakorn, MD, MPH
Assistant Professor of Ophthalmology and Pediatrics
Duke Ophthalmology
Duke University School of Medicine
Titilope Oduyebo, MD, MPH
Medical Officer
Division of Reproductive Health
National Center for Chronic Disease Prevention and Health Promotion
Centers for Disease Control and Prevention
At the conclusion of the session, the participant will be able to accomplish the following:
- Understand and apply the updated interim guidance for pregnant women with possible exposure to Zika virus in practice.
- Understand the latest estimates from the U.S. territories regarding pregnancy outcomes associated with Zika virus infection during pregnancy.
- Apply knowledge of pediatric ophthalmologic findings in infants when evaluating and managing infants with possible congenital Zika virus infection.
-
- Slides: View Nowpdf icon
- Webcast: Watch Nowmedia icon
- Audio: Listen Now
- Transcript: Read Now
- Audio conference call on Wednesday, 07/27/17: 2:00 - 3:00 PM (Eastern Time)
- Web-on-demand training after 3:00 PM on 07/27/17
- Materials: PowerPoint slide set
- https://www.cdc.gov/mmwr/volumes/66/wr/mm6629e1.htm?s_cid=mm6629e1_w
- https://www.cdc.gov/mmwr/volumes/66/wr/mm6623e1.htm
- https://www.cdc.gov/zika/pdfs/testing-algorithm-asymptomatic.pdfpdf icon
- https://www.cdc.gov/zika/pdfs/Testing_Algorithm.pdfpdf icon
- https://www.cdc.gov/zika/pdfs/lab-table.pdfpdf icon
- https://www.cdc.gov/zika/pdfs/when-to-test-zika.pdfpdf icon
- https://www.cdc.gov/zika
Accreditation Statements
Accreditation Statements
CME:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE:The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity provides 1.0 contact hour.
IACET CEU:The Centers for Disease Control and Prevention is authorized by IACET to offer 1.0 CEU's for this program.
CECH:Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designed for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
CPE:The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is 0387-0000-17-196-L04-P and enduring 0387-0000-17-196-H04-P course category.Course Category: This activity has been designated as knowledge-based.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
AAVSB/RACE:This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education in the jurisdictions which recognize AAVSB RACE approval. Please contact the AAVSB RACE Program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
CPH: The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credit for this program.
CDC is an approved provider of CPH Recertification Credits by the National Board of Public Health Examiners. Effective October 1, 2013, the National Board of Public Health Examiners (NBPHE) accepts continuing education units (CEU) for CPH recertification credits from CDC. Please select CEU as your choice for continuing education when registering for a course on TCEOnline. Learners seeking CPH should use the guidelines provided by the NBPHE for calculating recertification credits. For assistance please contact NBPHE at http://www.NBPHE.orgexternal icon.
There is no cost for this program.
DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
CDC does not accept commercial support.